In Re the Extradition of Zhenly Ye Gon

768 F. Supp. 2d 69, 69 A.L.R. Fed. 2d 633, 2011 U.S. Dist. LEXIS 12559, 2011 WL 565618
CourtDistrict Court, District of Columbia
DecidedFebruary 9, 2011
DocketMisc. 08-596 (JMF)
StatusPublished
Cited by10 cases

This text of 768 F. Supp. 2d 69 (In Re the Extradition of Zhenly Ye Gon) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re the Extradition of Zhenly Ye Gon, 768 F. Supp. 2d 69, 69 A.L.R. Fed. 2d 633, 2011 U.S. Dist. LEXIS 12559, 2011 WL 565618 (D.D.C. 2011).

Opinion

FINDINGS OF FACT AND CONCLUSIONS OF LAW

JOHN M. FACCIOLA, United States Magistrate Judge.

This case is before me for a certificate of extraditability. On September 15, 2008, the United States, acting on behalf of the Government of the United Mexican States (“Mexico”), pursuant to its formal request for the extradition of Zhenly Ye Gon (“Ye Gon”), filed a complaint. Complaint For Arrest With a View Towards Extradition (18 U.S.C. § 318k) [# 1] (“Compl.”). Hearings were held before me on February 2, May 14, and June 3, 2010.

BACKGROUND

Extradition proceedings are governed by 18 U.S.C. § 3184, et. seq., 1 and the terms of the extradition treaty between the country requesting extradition and the country in which the individual is found — here, the extradition treaty between Mexico and the United States. See Extradition Treaty, U.S.-Mex., May 4, 1978, 31 U.S.T. 5059, T.I.A.S. No. 9656 (“Treaty”). When presented with a complaint for extradition, by statute, a judge or magistrate judge must hold a hearing to consider the evidence of criminality presented by the requesting country and to determine whether it is “sufficient to sustain the charge[s] under the provisions of the proper treaty or convention.” 18 U.S.C. § 3184. If the judge finds the evidence sufficient, he or she must “certify the same” to the Secretary of State, who makes the final decision whether to surrender the individual “according to the stipulations of the treaty.” Ward v. Rutherford, 921 F.2d 286, 287 (D.C.Cir.1990). Significantly, “[a]n extradition hearing is not the occasion for an adjudication of guilt or innocence.” Messina v. United States, 728 F.2d 77, 80 (2d Cir.1984) (internal quotation marks and citations omitted). Rather, it is a preliminary examination, similar to that conducted by a magistrate judge in the context of a criminal defen *73 dant being held on a domestic charge, 2 “to determine whether a case is made out which will justify the holding of the accused and his surrender to the demanding nation.” United States v. Kember, 685 F.2d 451, 455 (D.C.Cir.1982), cert. denied, 459 U.S. 832, 103 S.Ct. 73, 74 L.Ed.2d 72 (1982).

An extradition certification is in order, therefore, where: 1) the judicial officer is authorized to conduct the extradition proceeding; 2) the court has jurisdiction over the fugitive; 3) the applicable treaty is in full force and effect; 4) the crimes for which surrender is requested are covered by the applicable treaty; and 5) there is sufficient evidence to support a finding of probable cause as to each charge for which extradition is sought. See Fernandez v. Phillips, 268 U.S. 311, 312, 45 S.Ct. 541, 69 L.Ed. 970 (1925); see also Foster v. Goldsoll, 48 App.D.C. 505, 517 (1919). Based on the following findings of fact, I conclude that those requirements are satisfied in this case.

FINDINGS OF FACT 3

1. Ye Gon is a Chinese national with Mexican citizenship who owned and operated businesses in and around Mexico City, Mexico. Aff. ¶¶ 32-36; Apdx. D at D-l, D-2(a), D-2(b), D-3, D-4.

2. Among those businesses was a pharmaceutical importing and brokering company named Unimed Pharm Chem (“Unimed”). Aff. ¶¶ 32-35; Apdx. D at D-2(a), D-2(b), D-3.

3. From 2003 to July 2005, Unimed legally imported 33.875 tons of ephedrine, pseudoephedrine, and pseudoephedrine hydrochloride pursuant to a permit from COFEPRIS. 4 Aff. ¶ 37; Apdx. D at D-5(a), D-5(b).

4. Ephedrine, pseudoephedrine, and pseudoephedrine hydrochloride are classified as psychotropic substances under Mexican health laws, and it is unlawful to import, transport, possess with intent to manufacture, or manufacture such psychotropic substances without a COFEPRIS permit. Apdx. B at 4-9; Apdx. D at D-49.

5. On September 24, 2003, Ye Gon contracted with a Chinese company named Chifeng Arker Pharmaceutical Technology Co., Ltd. (“Chifeng Arker”) to buy an “intermediate” chemical identified as “hydroxy benzyl-N-methylacetethamine” 5 which, according to the contract, was a precursor chemical that could be used to produce pseudoephedrine or pseudoephedrine hydrochloride. Aff. ¶¶ 37-40; Apdx. D at D-6(a).

6. Ye Gon and his senior chemist, Bernardo Mercado Jimenez (“Jimenez”), both *74 signed the contract on behalf of Unimed. Apdx. D at D-6(a).

7. According to the terms of the contract, Chifeng Arker agreed to sell and Unimed agreed to purchase a minimum of 50 tons of the chemical annually. Aff. ¶ 38; Apdx. D at D-6(a).

8. The contract also called for Chifeng Arker to provide technical support to aid Unimed in the actual production of pseudoephedrine, to include “workshop housing design.” Aff. ¶ 39; Apdx. D at D-6(a), D-6(b).

9. The Mexican government never issued a permit to Unimed or Ye Gon to manufacture psychotropic substances such as pseudoephedrine. Aff. ¶ 35; Apdx. D at D-5(a).

10. In 2003, when Ye Gon entered into this contract, Unimed was the fifth largest out of 19 importers of pseudoephedrine and ephedrine in Mexico; the next year, 2004, his company had more than doubled its pseudoephedrine and ephedrine imports, and had risen to third largest among 23 importers. See Ye Gon Trial Exhibit 199 at 17.

11. In 2004, the Mexican government determined that there was being imported into Mexico much more ephedrine and pseudoephedrine than was needed for lawful medical purposes and that, to prevent diversion of those substances for unlawful use, the amount permitted to be imported should be reduced. Aff. ¶¶ 43-44; Apdx. D at D-5(c).

12. Consistent with this policy change, on July 1, 2005, the Mexican Secretary of Health, acting through COFEPRIS, eliminated Unimed and seven other companies as authorized importers of psychotropic substances, including ephedrine and pseudoephedrine. Aff. ¶45; Apdx. D at D-9(a). 6

13. Despite the loss of permission to import psychotropic substances in July 2005, and despite the fact that he had not been authorized to manufacture psychotropic substances, in October 2005, Ye Gon began to build and equip a manufacturing plant in Toluca, Mexico, with the help of Chinese advisors, as contemplated by the September 2003 contract with Chifeng Arker. Aff. ¶¶ 5 3, 55-60; Apdx. A ¶¶82, 137; Apdx. D at D-6(a), D-19, D-20.

14. Ye Gon also knowingly imported psychotropic substances from China without the required permits on at least four occasions between December 2005 and December 2006.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Liuksila v. Lynch
District of Columbia, 2018
Liuksila v. Turner
351 F. Supp. 3d 166 (D.C. Circuit, 2018)
Zhenli Ye Gon v. Lynch
176 F. Supp. 3d 1 (District of Columbia, 2016)
Zhenli Gon v. Gerald Holt
774 F.3d 207 (Fourth Circuit, 2014)
In re the Extradition of Liuksila
74 F. Supp. 3d 4 (District of Columbia, 2014)
United States v. Liuksila
District of Columbia, 2014
Zhenli Ye Gon v. Holder
992 F. Supp. 2d 637 (W.D. Virginia, 2014)
Zhenli Ye Gon v. DC Office of the Attorney General
825 F. Supp. 2d 271 (District of Columbia, 2011)
ZHENLI YE GON v. Holder
825 F. Supp. 2d 278 (District of Columbia, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
768 F. Supp. 2d 69, 69 A.L.R. Fed. 2d 633, 2011 U.S. Dist. LEXIS 12559, 2011 WL 565618, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-the-extradition-of-zhenly-ye-gon-dcd-2011.